| Financial Year |
March 31 2023 |
| Monetary Funds |
58,160,978.27 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
172,734,367.42 |
| Accounts Receivable |
39,262,540.97 |
| Advances to Suppliers |
9,449,178.63 |
| Other Receivables |
13,408,962.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
210,336,601.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,888,725.55 |
| Total Current Assets |
509,867,073.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,690,737.75 |
| Investment Properties |
-- |
| Fixed Assetes |
400,971,547.11 |
| Under-construction Projects |
172,713,025.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
42,299,941.16 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
56,188,806.00 |
| Deferred Income Tax Assets |
21,227,970.36 |
| Other Non-Current Assets |
75,011,817.48 |
| Sub-Total of Non-Current Assets |
809,478,351.06 |
| Total Assets |
1,319,345,424.66 |
| Short-Term Loans |
66,088,333.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,860,100.00 |
| Accounts Payable |
227,895,352.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,444,068.40 |
| Taxes Payable |
5,578,994.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,451,066.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,881,934.24 |
| Other Current Liabilities |
173,120,017.02 |
| Sub-Total of Current Liabilities |
608,773,892.77 |
| Long-term Loans |
79,300,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,478,724.64 |
| Deferred Income Tax Liabilities |
8,824,108.29 |
| Other Non-Current Liabilities |
13,478.92 |
| Sub-Total of Non-Current Liabilities |
133,071,728.20 |
| Total Liabilities |
741,845,620.97 |
| Paid-In Capital(Or Share Stock) |
260,000,000.00 |
| Capital Surplus |
1,163,116,138.25 |
| Surplus Reserve |
38,694,973.38 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-890,427,268.33 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
577,499,803.69 |
| Owner's Equity（Stockholder's Equity） |
577,499,803.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,319,345,424.66 |
